echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Osteolytic glycol gadosithathacana can improve AIPC prognosis

    Osteolytic glycol gadosithathacana can improve AIPC prognosis

    • Last Update: 2020-07-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    U.Sand Canadian researchers have released the latest results from the ASCENT study: For patients with advanced non-androgen-dependent prostate cancer (AIPC) who are subjected to docetaxel chemotherapy, high doses of carnivorous trirol (calcitriol) can improve their prognosisThis randomized, multicenter clinical trial was conducted in the United States and Canada and included 250 patientsThese patients with progressive non-androgen-dependent prostate cancer took 45 micrograms of osteograms of ostrichol or placebo or 45 micrograms or placebo selonggelosphere seamount seamount seamounts 1 day before the application of Dosita, followed by an intravenous dose of dosita (dose 36 mg/m2) for a week after a week's restCompared to the docithalaplus placebo group, the overall survival rate of the Dosita-laced tricol treatment group improved significantly, by 49%, while the total prostate-specific antigen (PSA) response rate in the combined drug group increased by 63% and 52% respectively compared to the placebo groupIn addition, the incidence of severeadverse reactionssignificantly decreased compared to the placebo group, 41% and 27% respectively, and the incidence of thrombosis was significantly reduced in patients with osteosomel(White Ice)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.